Ciccone, M.

patient angina fluvastatin study effect group concentration cholesterol placebo lipid treatment intervention disease angina group event statin fluvastatin treatment heart atherosclerotic events incidence reduction result baseline article lipid concentrations infarction artery disease outcome atherosclerotic trial plaque angina fluvastatin end points point artery death prevention analysis difference lipoprotein pravastatin density percutaneou october visit lescol table change hospital discharge density lipoprotein heart disease serruy class feyter hospital classification downloaded lesion index benefit c h lee fasting triglyceride concentrations index procedure discharge blood cholesterol concentrations p r soares f saia angina groups m umans density lipoprotein cholesterol evidence angina pectoris novartis pharma ag circulation emergency department visits initiation cardiol treatment-status interaction analysis hmg-coa reductase inhibitors